694 related articles for article (PubMed ID: 18819815)
1. Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins.
Shrestha AR; Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Oct; 16(20):9161-70. PubMed ID: 18819815
[TBL] [Abstract][Full Text] [Related]
2. Antitumor studies. part 3: design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(N-substituted amino)-10-alkyl-2-deoxo-5-deazaflavins.
Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2007 Oct; 15(19):6336-52. PubMed ID: 17644399
[TBL] [Abstract][Full Text] [Related]
3. Antitumor studies. Part 1: design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents.
Ali HI; Tomita K; Akaho E; Kambara H; Miura S; Hayakawa H; Ashida N; Kawashima Y; Yamagishi T; Ikeya H; Yoneda F; Nagamatsu T
Bioorg Med Chem; 2007 Jan; 15(1):242-56. PubMed ID: 17049252
[TBL] [Abstract][Full Text] [Related]
4. Antitumor studies. Part 4: Design, synthesis, antitumor activity, and molecular docking study of novel 2-substituted 2-deoxoflavin-5-oxides, 2-deoxoalloxazine-5-oxides, and their 5-deaza analogs.
Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Jan; 16(2):922-40. PubMed ID: 17962027
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin-cholestane hybrid compounds.
Shrestha AR; Shindo T; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Sep; 16(18):8685-96. PubMed ID: 18723355
[TBL] [Abstract][Full Text] [Related]
6. Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.
Ali HI; Tomita K; Akaho E; Kunishima M; Kawashima Y; Yamagishi T; Ikeya H; Nagamatsu T
Eur J Med Chem; 2008 Jul; 43(7):1376-89. PubMed ID: 18055068
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Antitumor Activity and Molecular Docking Study of Novel 5-Deazaalloxazine Analogs.
Mahmoud S; Samaha D; Mohamed MS; Abou Taleb NA; Elsawy MA; Nagamatsu T; Ali HI
Molecules; 2020 May; 25(11):. PubMed ID: 32481639
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas.
Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E
Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-ones.
Xiao ZP; Li HQ; Shi L; Lv PC; Song ZC; Zhu HL
ChemMedChem; 2008 Jul; 3(7):1077-82. PubMed ID: 18433075
[TBL] [Abstract][Full Text] [Related]
12. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.
Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors.
Bhuva HA; Kini SG
J Mol Graph Model; 2010 Aug; 29(1):32-7. PubMed ID: 20493747
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.
Verones V; Flouquet N; Farce A; Carato P; Leonce S; Pfeiffer B; Berthelot P; Lebegue N
Eur J Med Chem; 2010 Dec; 45(12):5678-84. PubMed ID: 20884092
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel oxophenylarcyriaflavins as potential anticancer agents.
Bourderioux A; Bénéteau V; Mérour JY; Baldeyrou B; Ballot C; Lansiaux A; Bailly C; Le Guével R; Guillouzo C; Routier S
Org Biomol Chem; 2008 Jun; 6(12):2108-17. PubMed ID: 18528573
[TBL] [Abstract][Full Text] [Related]
20. Isolation, synthesis, and anti-tumor activities of a novel class of podocarpic diterpenes.
Xiong Y; Wang K; Pan Y; Sun H; Tu J
Bioorg Med Chem Lett; 2006 Feb; 16(4):786-9. PubMed ID: 16309905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]